Fuan Pharmaceutical (Group) Co (SZSE:300194) 3-Year EBITDA Growth Rate : 7.40% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co 3-Year EBITDA Growth Rate?

Fuan Pharmaceutical (Group) Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.12.

During the past 12 months, Fuan Pharmaceutical (Group) Co's average EBITDA Per Share Growth Rate was 31.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Fuan Pharmaceutical (Group) Co was 47.40% per year. The lowest was -41.50% per year. And the median was -6.20% per year.

Competitive Comparison of Fuan Pharmaceutical (Group) Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Fuan Pharmaceutical (Group) Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fuan Pharmaceutical (Group) Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuan Pharmaceutical (Group) Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Fuan Pharmaceutical (Group) Co's 3-Year EBITDA Growth Rate falls into.

Fuan Pharmaceutical (Group) Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Fuan Pharmaceutical (Group) Co (SZSE:300194) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Fuan Pharmaceutical (Group) Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Fuan Pharmaceutical (Group) Co (SZSE:300194) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254

Website

http://www.fapharm.com

Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.

Executives

Wu Xiong Hui	Executives
Huang Tao	Directors, executives
Feng Jing	Executives
Yu Xue Song	Directors, executives
Hong Rong Chuan	Executives
Tang Qin	Secretary, Director
Wang Tian Xiang	Director
Sun Yong Ping	Executives
Jiang Chen	Directors, executives
Huang Dao Fei	Supervisors
Wen Min	Director
Zhou Xu Dong	Executives
Zhou Zhong Sheng	Supervisors

Fuan Pharmaceutical (Group) Co (SZSE:300194) Headlines

No Headlines